Department of Cardiothoracic Surgery, Royal Brompton and Harefield Hospital, Harefield, UK.
Department of Vascular Surgery, Triemli Hospital, 497, 8063, Zurich, Switzerland.
BMC Surg. 2021 Feb 18;21(1):89. doi: 10.1186/s12893-021-01102-9.
Mesenteric ischemia is associated with poor outcome and high overall mortality. The aim was to analyze an interdisciplinary treatment approach of vascular and visceral specialists focusing on the in-hospital outcome and follow-up in patients with acute and acute-on-chronic mesenteric ischemia.
From 2010 until 2017, 26 consecutive patients with acute or acute on chronic mesenteric ischemia were treated by an interdisciplinary team. Data were prospectively collected and retrospectively evaluated. Throughout the initial examination, the extent of bowel resection was determined by the visceral surgeon and the appropriate mode of revascularization by the vascular surgeon. The routine follow-up included clinical examination and ultrasound- or CT-imaging for patency assessment and overall survival as primary endpoint of the study.
Out of 26 patients, 18 (69.2%) were rendered for open repair. Ten patients (38.5%) received reconstruction of the superior mesenteric artery with an iliac-mesenteric bypass. Seven patients (26.9%) underwent thrombembolectomy of the mesenteric artery. One patient received an infra-diaphragmatic aorto-celiac-mesenteric bypass. Out of the 8 patients, who were not suitable for open revascularization, 2 patients (7.7%) were treated endovascularly and 6 (23.1%) underwent explorative laparotomy. The in-hospital mortality was 23% (n = 6). The mean survival of the revascularized group (n = 20) was 51.8 months (95% CI 39.1-64.5) compared to 15.7 months in the non-revascularized group (n = 6) (95% CI - 4.8-36.1; p = 0.08). The median follow-up was 64.6 months. Primary patency in the 16 patients after open and 2 after interventional revascularization was 100% and 89.9% in the follow-up.
The interdisciplinary treatment of mesenteric ischemia improves survival if carried out in time. Hereby open revascularization measures are advantageous as they allow bowel assessment, resection, and revascularization in a one-stop fashion especially in advanced cases.
肠系膜缺血与不良预后和高总体死亡率相关。本研究旨在分析血管和内脏专科医生的跨学科治疗方法,重点关注急性和亚急性肠系膜缺血患者的住院结局和随访情况。
2010 年至 2017 年,26 例连续的急性或亚急性肠系膜缺血患者接受了跨学科团队的治疗。数据通过前瞻性收集和回顾性评估。在整个初始检查过程中,内脏外科医生确定肠切除术的范围,血管外科医生确定适当的血运重建方式。常规随访包括临床检查以及超声或 CT 成像,以评估通畅性和总生存率作为本研究的主要终点。
26 例患者中,18 例(69.2%)接受了开放修复。10 例(38.5%)患者接受了肠系膜上动脉的重建,包括髂-肠系膜旁路。7 例(26.9%)患者接受肠系膜动脉血栓切除术。1 例患者接受了膈下腹主动脉-腹腔干-肠系膜旁路。8 例不适合开放血运重建的患者中,2 例(7.7%)接受了血管内治疗,6 例(23.1%)接受了剖腹探查。住院死亡率为 23%(n=6)。接受血运重建的患者(n=20)的平均生存时间为 51.8 个月(95%CI 39.1-64.5),未接受血运重建的患者(n=6)的平均生存时间为 15.7 个月(95%CI -4.8-36.1;p=0.08)。中位随访时间为 64.6 个月。开放和 2 例介入血运重建后的 16 例患者的主要通畅率为 100%,随访时为 89.9%。
如果及时进行跨学科治疗,肠系膜缺血的治疗可提高生存率。在此,开放性血运重建措施具有优势,因为它们允许在一次手术中进行肠评估、切除和血运重建,特别是在晚期病例中。